|
|
MediBIC (TSE:2369) is a leading Japanese life sciences and pharmacogenomics consulting company. The company was founded in 2000 with the aim of helping the Japanese pharmaceutical industry to improve its drug development efficiency through strategic integration of technologies. The company has diversified into providing custom informatics solutions and partnering with other technology providers to form an in silico virtual discovery pipeline. MediBIC was recently named the fastest growing technology company in Japan by Deloitte Touche Tohmatsu, the global professional services organization. MediBIC’s rapid expansion allows DNA2.0 to help meet the needs of Japan’s growing market demand for new approaches in genomic drug discovery. DNA2.0 and MediBIC collaborate on new product research and development. MediBIC is also the exclusive Japanese distributor for the company’s existing repository of synthesized genes. The two companies are supporting Japanese life science companies engaged in the synthesis and development of improved enzymes and biomedical products as well as development of proteins with unique properties. See press release. |
|
info@DNA20.com
1 877 DNA TOGO
1 650 853 8347
europe@DNA20.com |
